iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Merck opens research -; development center in Bengaluru

2 Sep 2022 , 07:45 AM

The opening of Merck’s healthcare research and development centre in Bengaluru was announced on Thursday.

The Merck India R&D Excellence Centre helps treat patients with unmet medical needs all around the world by contributing to the company’s healthcare R&D.

About 300 employees are employed in the German pharmaceutical company’s centre, which will keep growing over the next two years.

“Through the Centre, we will increase our involvement in healthcare research and development in India while assisting the Merck Group’s international drug discovery activities. According to Suneela Thatte, vice president and director of the R&D Excellence Centre, the Bangalore centre’s goals are to create a culture of working as a single team, deliver important tasks related to medication development, and build a strong talent base. The statement was reported by ET.

Thatte continued, “The R&D Excellence Centre aspires to unite the finest of local talent and international best practices to enable the vision of increased patient outcomes.

For feedback and suggestions, write to us at editorial@iifl.com

 

Related Tags

  • Bengaluru
  • healthcare
  • RD
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.